A role for apoE in regulating the levels of α-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease

American Journal of Pathology

Volumn 155, Issue 3, 1999, Pages 869-875

  Licastro, Federico ^a,b   Campbell, Iain L ^d,e   Kincaid, Carrie ^e   Veinbergs, Isaac ^b   Van Uden, Emily ^b   Rockenstein, Edward ^b   Mallory, Margaret ^b   Gilbert, John R ^e   Masliah, Eliezer ^b,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BRAIN PROTEIN; MESSENGER RNA; SERINE PROTEINASE INHIBITOR;

AGING; ALLELE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; GENE DELETION; GENE EXPRESSION; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

EID: 0032886771     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65186-3     Document Type: Article

References (54)

1. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630
2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923
3. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S: Apolipoprotein E polymorphism, and Alzheimer's disease. Lancet 1993, 342:697-699
4. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993, 90:9649-9653
5. Wisniewski T, Haltia M, Ghiso J, Frangione B: Lewy bodies are immunoreactive with antibodies raised to gelsolin related amyloid-Finnish type. Am J Pathol 1991, 138:1077-1083
6. Feskens EJM, Havekes LM, Kalmijn S, De Knijff P, Launer LJ, Krombout D: Apolipoprotein E4 allele, and cognitive decline in elderly men. Br Med J 1994, 309:1202-1206
7. Plassman BL, Breitner JC: Apolipoprotein E, and cognitive decline in Alzheimer's disease. Neurology 1996, 47:317-320
8. Turgeon VL, Houenou LJ: The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system. Brain Res Brain Res Rev 1997, 25:85-95
9. 1-antichemotripsin in the brain amyloid deposits of Alzheimer disease. Cell 1988, 52:487-501
10. Fraser PE, Nguyen JT, McLachlan DR, Abraham CR, Kirschner DA: a1-Antichymotripsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro. J Neurochem 1993, 61:298-305
11. Ma J, Yee A, Brewer HB Jr, Das S, Potter H: Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994, 372:92-94
12. Eriksson S, Janciauskiene S, Lannfelt L: α1-antichymotrypsin regulates Alzheimer β-amyloid peptide fibril formation. Proc Natl Acad Sci USA 1995, 92:2313-2317
13. Pasternack JM, Abraham CR, Van Dyke BJ, Potter H, Younkin SG: Astrocytes in Alzheimer's disease gray matter express α-1-antichymotrypsin messenger RNA. Am J Pathol 1989, 135:827-834
14. Abraham CR: The role of acute-phase α-1-antichymotrypsin in brain dysfunction and injury. Res Immunol 1992, 143:631-636
15. Licastro F, Mallory M, Hansen LA, Masliah E: Increased levels of α-1-antichymotrypsin in brain of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE4 genotype. J Neuroimmunol 1998, 88:105-110
16. Inglis JD, Lee M, Davidson DR, Hill RE: Isolation of two cDNAs encoding novel α-1-antichymotrypsin-like proteins in a murine chondrocytic cell line. Gene 1991, 106:213-220
17. Campbell I, Abraham CR, Masliah E, Kemper Ph, Inglis JD, Oldstone MBA, Mucke L: Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc Natl Acad Sci USA 1993, 90:10061-10065
18. Willnow TE, Armstrong SA, Hammer RE, Herz J: Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc Natl Acad Sci USA 1995, 92:4537-4541
19. Plump AS, Smith JD, Hayek T, Aaalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353
20. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD: Neurodegeneration in the CNS of apoE-deficient mice. Exp Neurol 1995, 136:107-122
21. Xu P-T, Schmechel D, Rothrock-Christian T, Burkhart DS, Qiu H-L, Popko B, Sullivan P, Maeda N, Saunders AM, Roses AD, Gilbert JR: Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol Dis 1997, 1:1-18
22. Van Uden E, Veinbergs I, Mallory M, Orlando R, Masliah E: A novel role for receptor-associated protein in somatostatin modulation: implications for Alzheimer's disease. Neuroscience 1999, 88:687-700
23. Chiang CS, Stalder A. Samini A, Campbell IL: Reactive gliosis as a consequence of IL-6 expression in the brain: studies in transgenic mice. Dev Neurosci 1994, 16:212-221
24. + T cells from young and old mice. J Immunol 1993, 150:3602-3614
25. Hansen LA, Masliah E, Galasko D, Terry RD: Plaque only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993, 52:648-654
26. Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L: The apolipoprotein E allele 4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994, 44:1950-1951
27. Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS: Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981, 10:184-192
28. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemes J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J: Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995, 373:523-527
29. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with Folin phenol reagent. Biol Chem 1951, 193:265-272
30. Tanaka S, Chen X, Xia Y, Kang DE, Matoh N, Sundsmo M, Thomas RG. Katzman R, Thal LJ, Trojanowski JQ, Saitoh T, Ueda K, Masliah E: Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease. Neurology 1998, 50:1556-1562
31. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE: Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994, 264:850-852
32. Strickland DK, Kounnas MZ, Argraves WS: LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 1995, 9:890-898
33. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472
34. Kordula T, Rydel RE, Brigham EF, Horn F, Heinrich PC, Travis J: Oncostatin M, and the interleukin-6, and soluble interleukin-6 receptor complex regulate α-1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem 1998, 273:4112-4118
35. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA: A family of cytokine-inducible inhibitors of signalling. Nature 1997, 387:917-921
36. Igbavboa U, Avdulov NA, Chochina SV, Wood WG: Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor-apolipoprotein E, or both proteins, J Neurochem 1997, 69: 1661-1667
37. Janciauskiene S, Eriksson S: In vitro complex formation between cholesterol and α-1-proteinase inhibitor. FEBS Lett 1993, 316:269-272
38. Licastro F, Davis LJ, Pedrini S, Galasko D, Masliah E: Prostaglandin E2 induced polymerization of human α-1-antichymotrypsin, and suppressed its protease inhibitory activity: implications for Alzheimer's disease. Biochem Biophys Res Commun 1998, 249:182-186
39. Poirier J, Baccichet A, Dea D, Gauthier S: Cholesterol synthesis and lipoprotein reuptake during synaptic remodeling in hippocampus in adult rats. Neuroscience 1993, 55:81-90
40. Poirier J: Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994, 17:525-530
41. Masliah E, Mallory M, Alford M, Veinbergs I, Roses AD: Apolipoprotein E role in maintaining the integrity of the aging central nervous system. Apolipoprotein E and Alzheimer's Disease. Edited by Y Christen, AD Roses. New York, Springer-Verlag, 1995, pp 59-73
42. Veinbergs I, Masliah E: Synaptic alterations in apolipoprotein E knockout mice. Neuroscience 1999, 91:401-403
43. Chen Y, Lomnitski L, Michaelson DM, Shohami E: Motor and cognitive deficits in apolipoprotein E deficient mice after closed head injury. Neuroscience 1997, 80:1255-1262
44. Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS: Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J Cereb Blood Flow Metab 1997, 17:753-758
45. Veinbergs I, Jung MW, Young SJ, Van Uden E, Groves PM, Masliah E: Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice. Neurosci Lett 1998, 249:1-4
46. Anderson R, Higgins GA: Absence of central cholinergic deficits in apoE knockout mice. Psychopharmacology 1997, 132:135-144
47. Anderson R, Barnes JC, Bliss TVP, Cain DP, Cambon K, Davies HA, Errington ML, Fellows LA, Gray RA, Hoh T, Stewart M, Large CH, Higgins GA: Behavioral, physiological, and morphological analysis of a line of apolipoprotein E knockout mice. Neuroscience 1998, 85:93-110
48. Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB Jr: Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 1986, 78:815-821
49. Sun Y, Wu S, Bu G, Onifade MK, Patel SN, LaDu MJ, Fagan AM, Holtzman DM: Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci 1998, 18:3261-3272
50. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE: Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 1995, 270:27063-27071
51. Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley RW, Mucke L: Isoform-specific effects of human apolipoprotein E on brain function revealed in APOE knockout mice: increased susceptibility of females. Proc Natl Acad Sci USA 1998, 95:10914-10919
52. Cullen P, Cignarella A, Brennhausen B, Mohr S, Assmann G, von Eckardstein A: Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J Clin Invest 1998, 101:1670-1677
53. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL: Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA 1995, 92:9480-9484
54. Fagan AM, Bu G, Sun Y, Daugherty A, Holtzman DM: Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth, and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem 1996, 271:30121-30125